title: Mono-(3-carboxypropyl) phthalate, a metabolite of di-n-octyl phthalate.
abstract: Di-n-octyl phthalate (DnOP) is found as a component of mixed C6-C10 linear-chain phthalates used as plasticizers in various polyvinyl chloride applications, including flooring and carpet tiles. Following exposure and absorption, DnOP is metabolized to its hydrolytic monoester, mono-n-octyl phthalate (MnOP), and other oxidative products. The urinary levels of one of these oxidative metabolites, mono-(3-carboxypropyl) phthalate (MCPP), were about 560-fold higher than MnOP in Sprague-Dawley rats dosed with DnOP by gavage. Furthermore, MCPP was also found in the urine of rats dosed with di-isooctyl phthalate (DiOP), di-isononyl phthalate (DiNP), di-isodecyl phthalate (DiDP), di-(2-ethylhexyl) phthalate, and di-n-butyl phthalate (DBP), although at concentrations considerably lower than in rats given similar concentrations of DnOP. The comparatively much higher urinary concentrations of MCPP than of the hydrolytic monoesters of the high-molecular-weight phthalates DiOP, DiNP, and DiDP in the exposed rats suggest that these monoesters may be poor biomarkers of exposure to their precursor phthalates and may explain the relatively low frequency of detection of these monoester metabolites in human populations. MCPP and MnOP were also measured in 267 human urine samples. The frequent detection and higher urinary concentrations of MCPP than MnOP suggest that exposure to DnOP might be higher than previously thought based on the measurements of MnOP alone. However, because MCPP is also a minor metabolite of DBP and other phthalates in rats, and the metabolism of phthalates in rodents and humans may differ, additional data on the absorption, distribution, metabolism, and elimination of MCPP are needed to completely understand the extent of human exposure to DnOP from the urinary concentrations of MCPP.
authors.affiliation: Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA. ACalafat@cdc.gov
authors.forename: Antonia M
authors.initials: AM
authors.lastname: Calafat
authors.forename: Manori J
authors.initials: MJ
authors.lastname: Silva
authors.forename: John A
authors.initials: JA
authors.lastname: Reidy
authors.forename: L
authors.initials: L
authors.lastname: Earl Gray
authors.forename: Ella
authors.initials: E
authors.lastname: Samandar
authors.forename: James L
authors.initials: JL
authors.lastname: Preau
authors.forename: Arnetra R
authors.initials: AR
authors.lastname: Herbert
authors.forename: Larry L
authors.initials: LL
authors.lastname: Needham
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000652:urine; D004784:Environmental Monitoring; D004785:Environmental Pollutants / Q000493:pharmacokinetics / Q000652:urine; D005260:Female; D006801:Humans; D010795:Phthalic Acids / Q000493:pharmacokinetics* / Q000652:urine; D010968:Plasticizers / Q000493:pharmacokinetics*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D015415:Biomarkers; D004785:Environmental Pollutants; D010795:Phthalic Acids; D010968:Plasticizers